Citations 1
First-in-human study assessing safety and tolerability of REGN1979, a novel CD20xCD3 bispecific antibody, in patients with CD20+ B-cell malignancies previously treated with anti-CD20 therapy.
Brownstein, Carrie , Adriaens, Lieve, Ansell, Stephen M. , Patel, Snehal G. , Kostić, Ana , Trail, Pamela A. , Lowy, Israel , Kohrt, Holbrook Edwin, Bannerji, Rajat , Chavez, Julio C , Levy, Ronald , Advani, Ranjana H.
Journal of Clinical Oncology | March 7, 2019 | Volume: 33 | Issue: 15_suppl | Pages: TPS3089-TPS3089
